Patent Search
 
Weight Loss Patent

Weight loss compound and method of using

Weight loss abstract


A composition efficacious in aiding weight loss in humans includes a weight-reducing dosage of zinc acetate packaged together with a copper-depletion-preventing dosage of copper gluconate. The zinc acetate is present as essentially the sole active ingredient. The method of using the composition preferably includes administering the zinc acetate and copper gluconate three times per day. In an alternate embodiment, the composition may be administered twice per day. In addition, it has been found that the composition's efficacy is maximized by also imposing a low-fat dietary regime.

Weight loss claims


What is claimed is:

1. A method for effecting weight reduction in a human comprising the steps of:

providing a composition comprising as essentially a sole active ingredient a weight-reducing effective dosage of zinc acetate and a depletion-preventing dosage of copper; and

administering the composition three times per day.

2. The method recited in claim 1, wherein the composition comprises zinc acetate in a range of 40-60 mg.

3. The method recited in claim 1, wherein the composition comprises approximately 50 mg of zinc acetate.

4. The method recited in claim 1, wherein copper in the composition is present as copper gluconate.

5. The method recited in claim 1, wherein the composition comprises copper gluconate in a range of 0.7-2 mg.

6. The method recited in claim 1, wherein the composition comprises 1.3 mg of copper gluconate.

7. The method recited in claim 1, further comprising the step of instituting a dietary regime containing dietary fat in a range of 5 to 20 grams per day.

8. A method for effecting weight reduction in a human comprising the steps of:

providing a composition comprising as essentially a sole active ingredient a weight-reducing effective dosage of zinc acetate and a depletion-preventing dosage of copper; and

administering the composition twice per day.

9. The method recited in claim 8, wherein the composition comprises zinc acetate in a range of 60-90 mg.

10. The method recited in claim 8, wherein the composition comprises approximately 75 mg of zinc acetate.

11. The method recited in claim 8, wherein copper in the composition is present as copper gluconate.

12. The method recited in claim 8, wherein the composition comprises copper gluconate in a range of 1-3 mg.

13. The method recited in claim 8, wherein the composition comprises 2 mg of copper gluconate.

14. The method recited in claim 8, further comprising the step of instituting a dietary regime containing dietary fat in a range of 5 to 20 grams per day.

Weight loss description

FIELD OF THE INVENTION

The present invention relates to compositions efficacious in aiding weight loss and, more particularly, to such compositions for use by humans.

DESCRIPTION OF RELATED ART

In 1992 it was estimated that 50 million Americans would begin a diet. In a survey sponsored by the U.S. Food and Drug Agency and the National Heart, Lung, and Blood Institute of the National Institutes of Health (1991/1992), 5% of women and 2% of men attempted to lose weight with the use of diet pills. Those products considered by the FDA to be over-the-counter weight control drugs are primarily those containing the active ingredient phenylpropanolamine (PPA).

Although current wisdom has indicated that a persistent course of exercise and healthy eating habits is the most likely to succeed, Americans spend an estimated $30 billion a year on diet programs and products. Among such products, for which there is little or no evidence of efficacy, are diet patches (now banned by the FDA), "fat blockers," "starch blockers," "magnet" diet pills to "flush fat out of the body," glucomannan, fillers such as fiber-based products, and spirulina (a species of blue-green algae) (Source: U.S. FDA Brochure, "The Facts about Weight Loss Products and Programs," 1992).

Horrobin (U.S. Pat. No. 4,393,049) has disclosed the use of .gamma.-linolenic acid and dihomo-.gamma.-linolenic acid, alone and in combination with zinc, .beta.-lactam antibiotics, or other materials that influence prostaglandin imbalance to treat obesity. The zinc is believed to stimulate the biosynthesis of 1-series prostaglandins.

Gori (U.S. Pat. No. 4,784,861) discloses a preparation for controlling weight that includes fiber-containing materials and water-absorbant substances to form bulk and for providing a coating. In order to replace minerals carried out of the system by the fiber, minteral supplements are also provided, including zinc and copper.

Keane (U.S. Pat. No. 5,215,750) discloses the use of zinc gluconate for inclusion with an L-glutamine-based composition for weight loss or control.

The use of zinc acetate, an anticopper agent, has been utilized for the treatment of Wilson disease, a relatively rare disorder resulting in copper toxicity (see, for example, G. J. Brewer and V. Yuzbasiyan-Gurkan, "Wilson Disease," Medicine 71(3), 139-64, 1992). The recommended dosage is 50 mg three times per day. In monitoring patients it was found that serum amylase and lipase levels were mildly elevated during the early months of zinc therapy, which may be due to an increase in induction of the enzymes.

SUMMARY OF THE INVENTION

It is therefore an object of the present invention to provide a composition and method for aiding weight loss in a human.

This object is achieved by the composition of the present invention, which comprises a weight-reducing effective amount of zinc acetate. The zinc acetate is present as the sole active ingredient in the weight-loss process. The composition further comprises a depletion-preventing dosage of copper, preferably present in the form of copper gluconate.

The method comprises the steps of providing a composition comprising a weight-reducing effective dosage of zinc acetate and a depletion-preventing dosage of copper, and administering the composition two or three times per day. Again, the zinc acetate is present as the sole active ingredient in the weight-loss process.

The features that characterize the invention, both as to organization and method of operation, together with further objects and advantages thereof, will be better understood from the following description.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

A description of the preferred embodiments of the present invention will now be presented.

A preferred embodiment of the composition of the present invention comprises approximately 40-60 mg, and preferably 50 mg, of zinc acetate packaged with approximately 0.7-2 mg, and preferably 1.3 mg, of copper gluconate, for preventing a depletion of copper in the body. The package is for administering thrice per day,

An alternate embodiment of the composition comprises approximately 60-90 mg, and preferably 75 mg, of zinc acetate for administering 2 times per day and approximately 1-3 mg, and preferably 2 mg, of copper gluconate for administering twice per day.

A preferred embodiment of the method of the present invention comprises the step of administering a composition as outlined above of approximately 40-60, preferably 50, mg of zinc acetate packaged with 0.7-2, preferably 1.3, mg of copper gluconate three times per day.

An alternate embodiment of the method comprises the step of administering a composition as outlined above of approximately 60-90, preferably 75, mg of zinc acetate packaged with 1-3, preferably 2, mg of copper gluconate twice per day.

In order to maximize the efficacy of the method, preferably the method further comprises instituting a dietary regime containing dietary fat in a range of 5 to 20 grams of fat per day.

It may be appreciated by one skilled in the art that additional embodiments may be contemplated, including compositions comprising other salts of zinc and copper and administering the composition in other dosages and at different intervals.

In the foregoing description, certain terms have been used for brevity, clarity, and understanding, but no unnecessary limitations are to be implied therefrom beyond the requirements of the prior art, because such words are used for description purposes herein and are intended to be broadly construed. Moreover, the embodiments of the invention described herein are by way of example, and the scope of the invention is not limited to the exact details provided.

Having now described the invention, the composition, the use of preferred embodiments thereof, and the advantageous new and useful results obtained thereby, the new and useful constructions, and reasonable equivalents thereof obvious to those skilled in the art, are set forth in the appended claims.


Compositions and methods for body weight loss
Recoil force and weight loss simulation device
Supplemental dietary composition for promoting weight loss
Method and composition for enhancing weight loss

7074440 Compositions and methods for body weight loss
7056890 Combination therapy for effecting weight loss and treating obesity
7014852 Alkaline phosphatase to induce weight loss or to reduce weight gain
7011857 Weight loss compositions and methods for individuals who may have gastric hyperacidity
6784206 Corosolic acid formulation and its application for weight-loss management and blood sugar balance
6783504 Method of acupuncture and magnetic treatment for weight loss
6780440 Herbal compositions and methods for diabetes and weight loss management
6762035 Method and test strips for the measurement of fat loss during weight loss programs
6706697 Diabetic nutrition and weight loss drink compositions
6643385 System and method for weight-loss goal visualization and planning and business method for use therefor
6613356 Weight loss medication and method
6579500 Apparatus and method for determining weight loss of a heated material
6534085 Phytochemicals for promoting weight loss
6531162 Adrenergically-mediated weight loss product
6475530 Methods and compositions for producing weight loss
6436718 Apparatus and method for determining weight loss of a heated material
6420350 Weight loss product
6383482 Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus
6340482 Methods for inducing weight loss in a human with materials derived from Citrus varieties
6270756 Weight loss induced by alpha interferon and gamma interferon
6210702 Weight loss composition and method for losing weight
6204291 Process for promoting weight loss in overweight dogs
6071544 Dietary compositions and method for promoting healthy weight loss cats
4485805 Weight loss device and method
4407832 Processing of mushrooms with reduced weight loss

  Copyright © 2006 - 2015 Patent Information Search